Cargando…
Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
The temperature of a solid tumor is often dissimilar to baseline body temperature and, compared to healthy tissues, may be elevated, reduced, or a mix of both. The temperature of a tumor is dependent on metabolic activity and vascularization and can change due to tumor progression, treatment, or can...
Autores principales: | Knapp, Jason P., Kakish, Julia E., Bridle, Byram W., Speicher, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405776/ https://www.ncbi.nlm.nih.gov/pubmed/36009571 http://dx.doi.org/10.3390/biomedicines10082024 |
Ejemplares similares
-
Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019) -
Ferroptosis: friend or foe in cancer immunotherapy?
por: Demuynck, Robin, et al.
Publicado: (2023) -
Interleukin-21 in cancer immunotherapy: Friend or foe?
por: Stolfi, Carmine, et al.
Publicado: (2012) -
Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe?
por: Jensen, Agnete Witness Praest, et al.
Publicado: (2021) -
Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)